Quoin Pharmaceuticals Ltd. Deferred Costs, Noncurrent
Quoin Pharmaceuticals Ltd. (QNRX) had Deferred Costs, Noncurrent of $50.00 thousand as of 2022-09-30, per its 6-K filed 2022-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCosts · last filed 2022-11-10
- 2022-09-30: Deferred Costs, Noncurrent $50.00K.
- 2021-12-31: Deferred Costs, Noncurrent $50.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2022-09-30 | $50.00K 6-K · filed 2022-11-10 |
| 2021-12-31 | $50.00K 6-K · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |